Open Book Extracts (OBE) has announced it is in the process of achieving compliance with novel food regulations regarding the distribution of CBD ingredients.
OBE has made this transition by joining the European Industrial Hemp Association's (EIHA) Novel Food Consortium. The EIHA Novel Food Consortium, officially launched in June 2020, is the association's project aimed at clearing the way for hemp foods and extracts – including CBD – in the UK and European Union member states.
By joining the consortium, OBE is joining forces with other companies to pursue safety studies to provide safe and ready access to cannabinoid-based products throughout the UK and EU.
"We are witnessing a pivotal moment in history when the global appetite for access to cannabinoids is very high," said Dave Neundorfer, OBE CEO. "We see this in the U.S. with many recent positive discussions among U.S. congressional officials to pass legislation for federal legalization of cannabis but also new bills for CBD to be regulated as a dietary supplement. We appreciate the EIHA and its members working together to respond to a common challenge by investing in unprecedented studies and look forward to the EU quickly solidifying their plans to implement a parallel framework where these same studies can be applied. We are also pleased to offer our clients the ability to sublicense our membership in the Novel Foods Consortium to bring their premium CBD products to market in the UK and eventually the EU."
Powered by their cGMP operations in North Carolina, OBE offers a portfolio of cannabinoid isolates, including CBD, CBG, CBN, CBC, and THCV, all at greater than 99 percent purity, as well as formulation services and turnkey finished good manufacturing including edibles, softgels, tablets, tinctures and a full range of topical products.
"As OBE proceeds down the path to achieve compliance with world-wide regulations, we are positioned to become the leading global supplier of cannabinoids while continuing to maintain 100 percent dedication to premium quality, science-driven consistency, sustainability, transparency, and positive, trustworthy relationships with our clients and community,” Neundorfer said.